drugset / Trial / NCT02789150

Outcomes of Renal Function in Hepatorenal Syndrome (HRS) Determined By Comparison of Target Mean Arterial Pressure (MAP) of 65 - 70 Mmhg Versus ≥ 85 Mmhg

NCT02789150

Phase 0 Completed 18 enrolled University of Louisville
RandomizedParallel-groupOpen-labelTreatment

Summary

Comparing renal outcomes based on a Mean Arterail Pressure (MAP) of 65-7085mmhg versus a MAP of greater than or equal to 85mmhg

Timeline

Start
2015-01
Primary completion
2018-01-11
Completion
2018-01-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Norepinephrine Other / unclassified

Indications